Sterling Capital Management LLC
Position in ELAN — Elanco Animal Health Inc
CIK 1329883
CHARLOTTE, NC
Position in ELAN
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$397,142
-$263,088 QoQ
Shares Held
16,596
-43.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Sterling Capital Management LLC holds $21,914,421 across 40 Drug Manufacturers - Specialty & Generic names. ELAN ranks #6 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
450,992 | $13,583,878 | |
| 2 | VTRS |
Viatris Inc
|
232,342 | $3,138,940 | |
| 3 | ZTS |
Zoetis Inc.
|
8,983 | $1,061,880 | |
| 4 | HLN |
Haleon plc
|
94,183 | $942,771 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
1,429 | $847,368 | |
| 6 | ELAN |
Elanco Animal Health Inc
This page
|
16,596 | $397,142 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
22,625 | $281,228 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
11,270 | $254,702 |
All Filings in ELAN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $397,142 | 16,596 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $660,230 | 29,175 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $612,799 | 30,427 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $477,123 | 33,412 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $289,611 | 27,582 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $356,203 | 29,414 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $275,687 | 18,767 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||